Some hospitals not prepared for potential Ebola patients

Article

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease.

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease spread. 

Report: U.S. health care costs significantly higher than other countries

Under the watchful eye of the Centers for Disease Control and Prevention (CDC), Emory University Hospital in Atlanta is treating two American missionaries who were infected with the disease while in Liberia.

According to the CDC, symptoms of the disease include fever, headache, joint and muscle aches, weakness, diarrhea, vomiting, stomach pain, lack of appetite, and abnormal bleeding. Symptoms may appear anywhere from two to 21 days after exposure to ebolavirus. Ebola can be transmitted only through direct contact with blood or bodily fluids of a symptomatic person or through exposure to objects, such as needles, that have been contaminated.

A recent Fox News opinion piece noted that the danger comes from someone who is unknowingly infected with Ebola travels to the United States and goes to an emergency room after he becomes symptomatic.

“Many hospitals are poorly prepared to contain any pathogen. That’s why at least 75,000 people a year die from hospital infections,” writes Betsy McCaughey, PhD, former Lt. Governor of New York. 

“Whether Americans die of Ebola will depend largely on what hospitals do when the first victims unknowingly carrying the virus are admitted,” says Dr. McCaughey.

The CDC recently issued a notice reminding U.S. healthcare workers of the importance of taking steps to prevent the spread of this virus, how to test and

“The CDC also needs to improve its own infection control rigor. In the last three months, three incidents of the CDC mishandling pathogens-anthrax, avian flu, and smallpox-have come to light. Why assume the agency’s ready for Ebola?” writes Dr. McCaughey.

Formulary News: WHO okays experimental drug use in Ebola outbreak

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Priya S. Vakharia, MD; and Deepak Sambhara, MD, FASRS, provide tips to ensure effective comanagement between retina specialists, optometrists, and ophthalmologists.
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.